Lars Schlotawa

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 12

Top Topics

Extracellular Matrix

End Stage Renal Disease

Advanced Cancer

Top Venues

EMBO molecular medicine

Children (Basel, Switzerland)

Journal of inherited metabolic disease

This page only lists publications with an associated author ORCID identifier.

Publications

Lars Schlotawa, Karolina Tyka, Matthias Kettwig, Rebecca C Ahrens-Nicklas, Matthias G J Baud, Tea Berulava, Nicola Brunetti-Pierri, Alyssa L Gagne, Zackary M Herbst, Jean A Maguire, Jlenia Monfregola, Tonatiuh Pena Centeno, Karthikeyan Radhakrishnan, Sophie Schröder, Elisa A Waxman, Andrea Balabio, Thomas Dierks, Andre Fischer, Deborah L French, Michael H Gelb, Jutta Gärtner
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency. EMBO molecular medicine (2023)
Lars Schlotawa, Karolina Tyka, Matthias Kettwig, Rebecca C Ahrens-Nicklas, Matthias G J Baud, Tea Berulava, Nicola Brunetti-Pierri, Alyssa L Gagne, Zackary M Herbst, Jean A Maguire, Jlenia Monfregola, Tonatiuh Pena Centeno, Karthikeyan Radhakrishnan, Sophie Schröder, Elisa A Waxman, Andrea Balabio, Thomas Dierks, Andre Fischer, Deborah L French, Michael H Gelb, Jutta Gärtner
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency. EMBO molecular medicine 15 (3) (2023)
Lars Schlotawa, Karolina Tyka, Matthias Kettwig, Rebecca C Ahrens-Nicklas, Matthias G J Baud, Tea Berulava, Nicola Brunetti-Pierri, Alyssa L Gagne, Zackary M Herbst, Jean A Maguire, Jlenia Monfregola, Tonatiuh Pena Centeno, Karthikeyan Radhakrishnan, Sophie Schröder, Elisa A Waxman, Andrea Balabio, Thomas Dierks, Andre Fischer, Deborah L French, Michael H Gelb, Jutta Gärtner
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency. EMBO molecular medicine 15 (3) (2023)
Michael P Schittkowski, Sabine Naxer, Mohamed Elabbasy, Leonie Herholz, Vivian Breitling, Alan Finglas, Jutta Gärtner, Lars Schlotawa
Multiple Sulfatase Deficiency from an Ophthalmologist's Perspective-Case Report and Literature Review. Children (Basel, Switzerland) 10 (3) (2023)
Lars Schlotawa, Karolina Tyka, Matthias Kettwig, Rebecca C Ahrens-Nicklas, Matthias G J Baud, Tea Berulava, Nicola Brunetti-Pierri, Alyssa L Gagne, Zackary M Herbst, Jean A Maguire, Jlenia Monfregula, Tonatiuh Pena Centeno, Karthikeyan Radhakrishnan, Sophie Schröder, Elisa A Waxman, Andrea Balabio, Thomas Dierks, Andre Fischer, Deborah L French, Michael H Gelb, Jutta Gärtner
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency. EMBO molecular medicine (2023)
Lars Schlotawa, Karolina Tyka, Matthias Kettwig, Rebecca C Ahrens-Nicklas, Matthias G J Baud, Tea Berulava, Nicola Brunetti-Pierri, Alyssa L Gagne, Zackary M Herbst, Jean A Maguire, Jlenia Monfregola, Tonatiuh Pena Centeno, Karthikeyan Radhakrishnan, Sophie Schröder, Elisa A Waxman, Andrea Balabio, Thomas Dierks, Andre Fischer, Deborah L French, Michael H Gelb, Jutta Gärtner
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency. EMBO molecular medicine 15 (3) (2023)
Lars Schlotawa, Karolina Tyka, Matthias Kettwig, Rebecca C Ahrens-Nicklas, Matthias G J Baud, Tea Berulava, Nicola Brunetti-Pierri, Alyssa L Gagne, Zackary M Herbst, Jean A Maguire, Jlenia Monfregula, Tonatiuh Pena Centeno, Karthikeyan Radhakrishnan, Sophie Schröder, Elisa A Waxman, Andrea Balabio, Thomas Dierks, Andre Fischer, Deborah L French, Michael H Gelb, Jutta Gärtner
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency. EMBO molecular medicine (2023)
Lars Schlotawa, Karolina Tyka, Matthias Kettwig, Rebecca C Ahrens-Nicklas, Matthias G J Baud, Tea Berulava, Nicola Brunetti-Pierri, Alyssa L Gagne, Zackary M Herbst, Jean A Maguire, Jlenia Monfregola, Tonatiuh Pena Centeno, Karthikeyan Radhakrishnan, Sophie Schröder, Elisa A Waxman, Andrea Balabio, Thomas Dierks, Andre Fischer, Deborah L French, Michael H Gelb, Jutta Gärtner
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency. EMBO molecular medicine 15 (3) (2023)
Michael P Schittkowski, Sabine Naxer, Mohamed Elabbasy, Leonie Herholz, Vivian Breitling, Alan Finglas, Jutta Gärtner, Lars Schlotawa
Multiple Sulfatase Deficiency from an Ophthalmologist's Perspective-Case Report and Literature Review. Children (Basel, Switzerland) 10 (3) (2023)
Lars Schlotawa, Ana Lopez, Gentzane Sanchez-Elexpuru, Sylwia D Tyrkalska, David C Rubinsztein, Angeleen Fleming
An inducible expression system for the manipulation of autophagic flux in vivo . Autophagy (2022)
Lars Schlotawa, Joana Preiskorn, Rebecca C Ahrens-Nicklas, Stina Schiller, Laura A Adang, Jutta Gärtner, Tim Friede
A systematic review and meta-analysis of published cases reveals the natural disease history in multiple sulfatase deficiency. Journal of inherited metabolic disease 43 (6) (2020)
Lars Schlotawa, Thomas Dierks, Sophie Christoph, Eva Cloppenburg, Andreas Ohlenbusch, G Christoph Korenke, Jutta Gärtner
Severe neonatal multiple sulfatase deficiency presenting with hydrops fetalis in a preterm birth patient. JIMD reports 49 (1) (2019)